Article

AT(1) angiotensin II receptor and novel non-AT(1), non-AT(2) angiotensin II/III binding site in brainstem cardiovascular regulatory centers of the spontaneously hypertensive rat

Biological Sciences, Northwest Missouri State University, Maryville, MO 64468, USA.
Brain research (Impact Factor: 2.83). 11/2010; 1359:98-106. DOI: 10.1016/j.brainres.2010.08.081
Source: PubMed

ABSTRACT Spontaneously hypertensive rats (SHR) have an activated brain angiotensin system that contributes to the elevation of blood pressure in this animal model. Physiological and pharmacological studies suggest that hyperactivation of brain AT₁ angiotensin receptors is a major pathophysiological factor. Consistent with these observations, radioligand binding studies indicate widespread up-regulation of brain angiotensin receptors in SHR. One key brainstem site in which AT₁ receptor stimulation appears to contribute to the elevated blood pressure in SHR is the rostral ventrolateral medulla (RVLM). However, no quantitative comparison of AT₁ receptor binding in the RVLM has been made in SHR versus normotensive rats. A novel, non-AT₁, non-AT₂ binding site, specific for angiotensins II and III, has recently been discovered in the brain. To determine if radioligand binding to either AT₁ receptors or this novel angiotensin binding site is altered in the RVLM and other caudal brainstem regions of SHR, a quantitative densitometric autoradiographic comparison of radioligand binding in SHR versus normotensive Wistar-Kyoto rats was made. In both the RVLM and caudal ventrolateral medulla (CVLM) as well as dorsomedial medulla (DMM), there was increased expression of AT₁ receptor binding in SHR (13%, 9%, and 23%, respectively). Conversely, expression of the novel, non-AT₁, non-AT₂, angiotensin II and III binding site was decreased in the RVLM and DMM of SHR (37% and 13%, respectively). This increased AT₁ receptor binding in the RVLM may contribute to the hypertension of SHR. Reduced radioligand binding to the novel, non-AT₁, non-AT₂, angiotensin binding site in the RVLM of SHR may indicate a role for this binding site to reduce blood pressure via its interactions with angiotensins II and III.

0 Followers
 · 
217 Views
  • Source
    • "Leptin Insulin resistance [10, 15, 29, 38–41] [1,2] [24, 48] [24, 48] [24, 47, 48] [10] [11] [12] [13] [14] [15] Renin-angiotensin system [3–6, 29, 57–70] [16, 17] [61] [62] Brain AT 1 receptor Figure 1: A schema presenting our concept in the regulation of sympathetic nervous system mediated by brain renin-angiotensin system in the metabolic syndrome. The numbers on the different arrows are the references from the bibliography. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Renin-angiotensin system (RAS) is activated in metabolic syndrome (MetS), and RAS inhibitors are preferred for the treatments of hypertension with MetS. Although RAS activation is important for the therapeutic target, underlying sympathetic nervous system (SNS) activation is critically involved and should not be neglected in the pathogenesis of hypertension with MetS. In fact, previous studies have suggested that SNS activation has the interaction with RAS activation and/or insulin resistance. As a novel aspect connecting the importance of SNS and RAS activation, we and other investigators have recently demonstrated that angiotensin II type 1 receptor (ATR) blockers (ARBs) improve SNS activation in patients with MetS. In the animal studies, SNS activation is regulated by the ATR-induced oxidative stress in the brain. We have also demonstrated that orally administered ARBs cause sympathoinhibition independent of the depressor effects in dietary-induced hypertensive rats. Interestingly, these benefits on SNS activation of ARBs in clinical and animal studies are not class effects of ARBs. In conclusion, SNS activation associated with RAS activation in the brain should be the target of the treatment, and ARBs could have the potential benefit on SNS activation in patients with MetS.
    02/2013; 2013:406897. DOI:10.1155/2013/406897
  • Source
    • "Bourassa et al. [45] demonstrated that AT1 receptor binding in both RVLM and caudal ventrolateral medulla as well as dorsomedial medulla was increased in SHR compared with normotensive rats. Conversely, expression of the novel, non-AT1, non-AT2, Ang II and III binding site, which was recently discovered, might be decreased in the RVLM and dorsomedial medulla of SHR [45]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Many Studies suggest that changes in sympathetic nerve activity in the central nervous system might have a crucial role in blood pressure control. The present paper discusses evidence in support of the concept that the brain renin-angiotensin system (RAS) might be linked to sympathetic nerve activity in hypertension. The amount of neurotransmitter release from sympathetic nerve endings can be regulated by presynaptic receptors located on nerve terminals. It has been proposed that alterations in sympathetic nervous activity in the central nervous system of hypertension might be partially due to abnormalities in presynaptic modulation of neurotransmitter release. Recent evidence indicates that all components of the RAS have been identified in the brain. It has been proposed that the brain RAS may actively participate in the modulation of neurotransmitter release and influence the central sympathetic outflow to the periphery. This paper summarizes the results of studies to evaluate the possible relationship between the brain RAS and sympathetic neurotransmitter release in the central nervous system of hypertension.
    11/2012; 2012:474870. DOI:10.1155/2012/474870
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The author's ten-year experience with training large-scale ANN models with the PCA-CG algorithm that generates a non-random initial connection weight set is presented. The suggested small number of hidden neurons and automatic identification and removal of the less relevant inputs increases the robustness of these models. Examples of ANN modeling of "artificial nose" sensor array, TV program rating and e-mail letter importance classification demonstrate the algorithm efficiency
    Neural Networks, 2002. IJCNN '02. Proceedings of the 2002 International Joint Conference on; 02/2002
Show more